Li Li

FDA investigator

Appears on 4 documents from 2015 to 2018, mostly at sites in New Jersey. Most often cites corrective and preventive action (21 CFR 820.100(a)).

4
Documents on file
2.5
Observations per 483
2015
First seen
2018
Most recent

What they cite most

From 10 observations

Activity by year

2015: 1, 2016: 1, 2018: 2

Where

New Jersey 4

Is Li Li coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 AS Software, IncAug 16, 2018 · Englewood Cliffs, New Jersey
483 Parker Laboratories, IncMar 20, 2018 · Fairfield, New Jersey
483 Mindray DS USA, Inc. dba Mindray NorthMar 31, 2016 · Mahwah, New Jersey
483 Fujifilm Medical Systems U.S.A., Inc.Apr 9, 2015 · Wayne, New Jersey

About this profile

What does Li Li inspect?

Li Li appears on 4 documents on file covering 4 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 820.100(a) (corrective and preventive action), followed by 21 CFR 820.198(a) and 21 CFR 806.10(a)(1).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Li Li is dated Aug 16, 2018.

FDA Investigator Li Li: 483s & Inspections · FDA Intel